semaglutide liraglutide difference Comparing Ozempic, Wegovy and Other GLP-1 Drugs Liraglutide vs Semaglutide vs GLP-1

Jonsson noted that Lillys clinical trials showed that almost half of participants saw such improvements that they no longer had symptoms associated with OSA. The approval is the second indication for Zepbound, which was approved for weight loss for those with obesity, or who are overweight and have a weight-related health condition, in November 2023

Patients experiencing persistent or concerning symptoms should contact their healthcare provider instead of relying on information found through social media or online discussion groups

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

For others, Wegovys established cardiovascular benefits may guide the decision

[DOI] [PMC free article] [PubMed] [Google Scholar] 16.Bernsmeier C, Meyer-Gerspach AC, Blaser LS, et al